Business
ABIONYX Pharma Announces Its Financial Calendar for the Year 2026
TOULOUSE, France & FULLERTON, Calif., January 23, 2026--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I–based technology platform, today announces its financial calendar for 2026.
About this update from Abionyx Pharma Sa
[{"type":"text","content":"TOULOUSE, France & FULLERTON, Calif., January 23, 2026--(BUSINESS WIRE)--Regulatory News:","length":93,"tagName":"p"},{"type":"text","content":"ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I–based technology platform, today announces its financial calendar for 2026.","length":261,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;background-color:#CCEEFF;width:61%;padding-left:15.0px;","val":[{"type":"text","content":"Events","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;background-color:#CCEEFF;padding-left:0.0px;width:39%;","val":[{"type":"text","content":"Dates*","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;width:61%;white-space:nowrap;padding-left:15.0px;","val":[{"type":"text","content":"Cash position and activity update for Q4 2025","length":45,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;width:39%;white-space:nowrap;padding-left:0.0px;","val":[{"type":"text","content":"Thursday, February 26, 2026","length":27,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;width:61%;padding-left:15.0px;","val":[{"type":"text","content":"2025 Full-Year Results","length":22,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;padding-left:0.0px;width:39%;","val":[{"type":"text","content":"Thursday, March 12, 2026","length":24,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;width:61%;padding-left:15.0px;","val":[{"type":"text","content":"Cash position and activity update for Q1 2026","length":45,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;padding-left:0.0px;width:39%;","val":[{"type":"text","content":"Thursday, May 28, 2026","length":22,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"border-bottom:solid black 1.0pt;wi...